汇聚群英智慧,闪亮你我星光
Together, Spark Biomedicine!
Join Bioverse webinar episode 9 to learn the essential role of chemistry, manufacturing, and control (CMC) in the global drug development and deal-making for ADC, radiopharmaceutical, and CGT. In this webinar, you would learn:
-
Review of recent debacles caused by laps in CMC
-
CMC’s essential role in the global drug development
-
CMC’s essential role in the global deal-making
-
Special concerns for ADC, Radiopharmaceuticals, or CGT
Event details
主题:BioVerse episode 9 – The Essential Role of CMC for the Global Drug Development and Deal-making in ADC, Raiopharmaceutical, and Cell & Gene Therapy
时间: 2024年5月8日 Wed 9:00 AM(EST)/ 2024年5月8日 周三 9:00 PM(北京时间)
地点: 药时代视频号
Speakers intro
Jing Fan, PhD
CEO of Hopstem Biotechnology
Jimmy Li, PhD
CEO of WuXi XDC
Gary Li, PhD
Leon ‘Jun’ Tang, PhD
(BioVerse webinar host)
Organizer
Partner &Collaborators
2024年至今:24笔并购(M&A)交易,总金额520.2亿美元,单笔金额都远低于2023年
数量缩减!2024年阿尔茨海默病在研管线分析
讲好新药的故事,打造下一个繁花时代!——创新药PR沙龙首届活动成功举办
本篇文章来源于微信公众号: 药时代
发布者:haitao.zhao,转载请首先联系contact@drugtimes.cn获得授权